Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 100

1.
2.

[Health technology assessment report: Computer-assisted Pap test for cervical cancer screening].

Della Palma P, Moresco L, Giorgi Rossi P.

Epidemiol Prev. 2012 Sep-Oct;36(5 Suppl 3):e1-43. Italian.

3.
4.

Predictors of breast and cervical cancer screening in a Spanish metropolitan area.

López-de-Andrés A, Martin-Lopez R, Hernández-Barrera V, Carrasco-Garrido P, Gil-de-Miguel A, Esteban y Peña MM, Jiménez-García R.

J Womens Health (Larchmt). 2010 Sep;19(9):1675-81. doi: 10.1089/jwh.2009.1828.

PMID:
20799924
5.

Adherence to breast and cervical cancer screening in Spanish women with diabetes: associated factors and trend between 2006 and 2010.

Martinez-Huedo MA, Lopez de Andres A, Hernandez-Barrera V, Carrasco-Garrido P, Martinez Hernandez D, Jiménez-Garcia R.

Diabetes Metab. 2012 Apr;38(2):142-8. doi: 10.1016/j.diabet.2011.09.007. Epub 2011 Nov 9.

6.

Socioeconomic disparities in the uptake of breast and cervical cancer screening in Italy: a cross sectional study.

Damiani G, Federico B, Basso D, Ronconi A, Bianchi CB, Anzellotti GM, Nasi G, Sassi F, Ricciardi W.

BMC Public Health. 2012 Feb 3;12:99. doi: 10.1186/1471-2458-12-99.

8.

Costs and benefits of different strategies to screen for cervical cancer in less-developed countries.

Mandelblatt JS, Lawrence WF, Gaffikin L, Limpahayom KK, Lumbiganon P, Warakamin S, King J, Yi B, Ringers P, Blumenthal PD.

J Natl Cancer Inst. 2002 Oct 2;94(19):1469-83.

9.
10.

[Attendance rate in the Polish Cervical Cancer Screening Program in the years 2007-2009].

Spaczyński M, Karowicz-Bilinska A, Rokita W, Molińska-Glura M, Januszek-Michalecka L, Seroczyński P, Uchlik J, Nowak-Markwitz E.

Ginekol Pol. 2010 Sep;81(9):655-63. Polish.

PMID:
20973201
11.

Awareness and uptake of colorectal, breast, cervical and prostate cancer screening tests in Spain.

Carrasco-Garrido P, Hernandez-Barrera V, Lopez de Andres A, Jimenez-Trujillo I, Gallardo Pino C, Jimenez-Garcıa R.

Eur J Public Health. 2014 Apr;24(2):264-70. doi: 10.1093/eurpub/ckt089. Epub 2013 Jun 27.

12.

Estimating personal costs incurred by a woman participating in mammography screening in the National Breast and Cervical Cancer Early Detection Program.

Ekwueme DU, Hall IJ, Richardson LC, Gardner JG, Royalty J, Thompson TD.

Cancer. 2008 Aug 1;113(3):592-601. doi: 10.1002/cncr.23613.

13.
14.

Economic evaluation of policy options for prevention and control of cervical cancer in Thailand.

Praditsitthikorn N, Teerawattananon Y, Tantivess S, Limwattananon S, Riewpaiboon A, Chichareon S, Ieumwananonthachai N, Tangcharoensathien V.

Pharmacoeconomics. 2011 Sep;29(9):781-806. doi: 10.2165/11586560-000000000-00000.

PMID:
21838332
15.

Educational level, voluntary private health insurance and opportunistic cancer screening among women in Catalonia (Spain).

Borràs JM, Guillen M, Sánchez V, Juncà S, Vicente R.

Eur J Cancer Prev. 1999 Oct;8(5):427-34.

PMID:
10548398
16.

Effect of a mobile unit on changes in knowledge and use of cervical cancer screening among rural Thai women.

Swaddiwudhipong W, Chaovakiratipong C, Nguntra P, Mahasakpan P, Lerdlukanavonge P, Koonchote S.

Int J Epidemiol. 1995 Jun;24(3):493-8.

PMID:
7672887
17.

Cost-effectiveness analysis for Pap smear screening and human papillomavirus DNA testing and vaccination.

Chen MK, Hung HF, Duffy S, Yen AM, Chen HH.

J Eval Clin Pract. 2011 Dec;17(6):1050-8. doi: 10.1111/j.1365-2753.2010.01453.x. Epub 2011 Jun 16.

PMID:
21679279
18.
19.

[The cost of screening for breast and cervical cancer in France].

Watt S.

Bull Cancer. 2003 Nov;90(11):997-1004. French.

PMID:
14706904
20.
Items per page

Supplemental Content

Write to the Help Desk